Mahoney Christopher purchased $689K of BG

Mahoney Christopher purchased 6,500 shares of Bunge Global SA (BG) at an average of $106.01 ($105.53–$107.60, $0.69M total) across 2 trades over 2026-07-31 to 2026-08-04.

Original reporting
SEC EDGAR · Mahoney Christopher
Published Aug 4, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 6:22 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$BG
Bullish
low confidence
Mentioned
$BG
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BGBullishLow
01

Why it matters

A director open-market purchase of 6,500 shares is newly disclosed, but it does not include any new guidance, contract, or regulatory development.

02

Market read

Traders may note the insider buy as a small sentiment input, but it is unlikely to materially change valuation without other catalysts.

03

What to watch

The article does not state intent, option exercises, or whether the director’s prior holdings were already large; without context, the buy size may be less informative.

Relevance 6/10Novelty 3/10Timing: filed 2026-08-04, covers buys from 2026-07-31 to 2026-08-04

Background

The article is an SEC Form 4 insider transaction disclosure for Bunge Global SA (BG).

Company-level read

Ticker impact

$BGBullishLow confidence
Context

Bunge Global SA director Christopher Mahoney bought 6,500 shares in open-market trades for about $689,050, per a fresh Form 4 filed Aug 4.

Expected impact

Likely limited near-term price impact; any effect is sentiment-driven and small versus earnings or guidance.

Evidence & confidence

The filing is a routine insider transaction with no 10b5-1 plan and no accompanying company-specific operational or financial disclosure.

Market effects

No direct sector read-through; insider buys are company-specific and typically do not reset sector expectations.

None indicated.

None indicated.

Counterpoint

Insider buys can be driven by diversification, liquidity needs, or pre-planned behavior, so the signal may be weak.

Key entities

  • Bunge Global SA

    Subject of the Form 4 insider transaction disclosure.

  • Christopher Mahoney

    Director who purchased shares in open-market trades.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BGMed

What Bunge Global (BG) Said on Its Q3 Earnings Call

Bunge Global (BG) reported Q3 earnings with mixed results. Grain merchandising gains were offset by weaker ocean freight and milling results. CEO Greg Heckman highlighted integration progress with Viterra, expecting $200M in cost savings by 2026. The company anticipates $0.50 per share from synergies in 2027. Bunge generated $2B in adjusted funds from operations, with $1.6B in discretionary cash flow.

$BGHighAI 9/10

Bunge (BG) Q3 2026 Earnings Call Transcript

Bunge (BG) reported Q3 2026 EPS of $1.64, up from $0.86 in 2025. Adjusted EPS was $2.56, with adjusted EBIT at $997M. The company maintained its full-year adjusted EPS guidance of $9.25-$9.75. Bunge highlighted progress from its Viterra combination, including cost savings and new projects. It also announced the sale of non-core sugar mills in Brazil. The company's liquidity position remains strong, with $9.7B in credit facilities.

$BGMedAI 8/10

Bunge Global 3Q 2026: Revenue $23.8B, Net income $318M, EPS $1.64— 10-Q Summary

Bunge Global reported Q3 2026 revenue of $23.8B, net income of $318M, and EPS of $1.64, up from $22.16B, $166M, and $0.84 respectively in the prior-year quarter. Nine-month net sales rose 50% to $69.7B, driven by Viterra and higher commodity prices. Soybean and softseed segment EBIT increased significantly, while sugarcane mill sale charges and Ukraine-related inventory damage weighed on results.

$BGHighAI 8/10

Bunge Q3 2026 slides: earnings beat offset by rising costs

Bunge (BG) reported Q3 2026 adjusted EPS of $2.56, beating estimates but shares fell slightly due to higher costs. The company maintained full-year guidance and highlighted benefits from Viterra integration. Adjusted segment EBIT rose 7.9% YoY, with strong performance in soybean and softseed processing, but declines in tropical oils and grain merchandising.

$BGMedAI 8/10

Bunge Q3 2026: Net Income $318 Million, Adjusted EPS $2.56

Bunge reported Q3 2026 net income of $318M, up from $166M YoY. Adjusted EPS was $2.56, and revenue reached $23.8B. The company maintained its full-year adjusted EPS outlook of $9.25-$9.75. Soybean processing improved, while Tropical Oils faced geopolitical disruptions. Bunge also announced the sale of two Brazilian sugarcane mills and progress on Viterra synergies.